Acasti Pharma Inc.

NASDAQ: ACST · Real-Time Price · USD
3.37
0.13 (4.01%)
At close: Oct 25, 2024, 10:00 PM

Acasti Pharma Ratios and Metrics

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
PE Ratio
-3.11 -2.56 -0.48 -4.58
PEG Ratio
0.07 0.03 -0.00 0.06
PS Ratio
n/a n/a n/a n/a
PB Ratio
0.60 0.53 0.30 0.42
P/FCF Ratio
-2.66 -2.66 -1.29 -2.61
P/OCF Ratio
-2.66 -2.67 -1.29 -2.61
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
n/a n/a 0.01 0.00
Quick Ratio
11.77 14.26 8.59 13.97
Current Ratio
11.77 14.26 8.59 13.97
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a -12.42 -0.36 -69.59
Return on Equity
-0.19 -0.21 -0.62 -0.09
Return on Assets
-0.18 -0.18 -0.54 -0.08
Return on Invested Capital
n/a -0.14 -0.27 -0.12
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a